Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2025-07-14
Product name:
XIPERE
DIN:
02559358
Product Monograph/Veterinary Labelling:
Date:
2025-07-14
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAUSCH & LOMB INC
1400 N Goodman Street
Rochester
New York
United States
14609
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Suprachoroidal
Number of active ingredient(s):
1
Schedule(s):
PRESCRIPTION
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01BA05 TRIAMCINOLONE
Active ingredient group (AIG) number:See footnote5
0106310006
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| TRIAMCINOLONE ACETONIDE | 40 MG / ML |